menu search

Uipath (path) gains but lags market: what you should know

Uipath (PATH) closed at $32.40 in the latest trading session, marking a +0.97% move from the prior day....

February 24, 2022, 7:15 pm

Uipath (path) gains but lags market: what you should know

Uipath (PATH) closed at $32.40 in the latest trading session, marking a +0.97% move from the prior day....

February 24, 2022, 7:15 pm

Uipath: automation tech company, 58% growth, 10% net cash

UiPath: Automation Tech Company, 58% Growth, 10% Net Cash...

February 24, 2022, 4:29 pm

Uipath: automation tech company, 58% growth, 10% net cash

UiPath: Automation Tech Company, 58% Growth, 10% Net Cash...

February 24, 2022, 4:29 pm

Uipath: automation tech company, 58% growth, 10% net cash

UiPath: Automation Tech Company, 58% Growth, 10% Net Cash...

February 24, 2022, 4:29 pm

What's going on with baidu and pinduoduo shares today?

Shares of several Chinese companies, including Baidu Inc (NASDAQ: BIDU) and Pinduoduo Inc - ADR (NASDAQ: PDD), are trading lower following the Russian...

February 24, 2022, 3:12 pm

What's going on with baidu and pinduoduo shares today?

Shares of several Chinese companies, including Baidu Inc (NASDAQ: BIDU) and Pinduoduo Inc - ADR (NASDAQ: PDD), are trading lower following the Russian...

February 24, 2022, 3:12 pm

What's going on with baidu and pinduoduo shares today?

Shares of several Chinese companies, including Baidu Inc (NASDAQ: BIDU) and Pinduoduo Inc - ADR (NASDAQ: PDD), are trading lower following the Russian...

February 24, 2022, 3:12 pm

Compass pathways plc (cmps) ceo george goldsmith on q4 2021 results - earnings call transcript

COMPASS Pathways plc (CMPS) CEO George Goldsmith on Q4 2021 Results - Earnings Call Transcript...

February 24, 2022, 11:13 am

Compass pathways plc (cmps) ceo george goldsmith on q4 2021 results - earnings call transcript

COMPASS Pathways plc (CMPS) CEO George Goldsmith on Q4 2021 Results - Earnings Call Transcript...

February 24, 2022, 11:13 am

Compass pathways plc (cmps) ceo george goldsmith on q4 2021 results - earnings call transcript

COMPASS Pathways plc (CMPS) CEO George Goldsmith on Q4 2021 Results - Earnings Call Transcript...

February 24, 2022, 11:13 am

Gold's path to $2k: fed rate hikes won't hurt gold price rally this year, says wells fargo

(Kitco News) - The gold's bull market won't be stopped by the slate of upcoming Federal Reserve rate hikes expected to begin in March, according to We...

February 23, 2022, 5:08 pm

Gold's path to $2k: fed rate hikes won't hurt gold price rally this year, says wells fargo

(Kitco News) - The gold's bull market won't be stopped by the slate of upcoming Federal Reserve rate hikes expected to begin in March, according to We...

February 23, 2022, 5:08 pm

Gold's path to $2k: fed rate hikes won't hurt gold price rally this year, says wells fargo

(Kitco News) - The gold's bull market won't be stopped by the slate of upcoming Federal Reserve rate hikes expected to begin in March, according to We...

February 23, 2022, 5:08 pm

The ratings game: intel is on a ‘long and expensive' road but stock may not ‘meaningfully underperform further,' analyst says

Intel Corp. is on a “long and expensive” path as it tries to recapture its former glory, but its st...

February 23, 2022, 11:40 am

The ratings game: intel is on a ‘long and expensive' road but stock may not ‘meaningfully underperform further,' analyst says

Intel Corp. is on a “long and expensive” path as it tries to recapture its former glory, but its st...

February 23, 2022, 11:40 am

The ratings game: intel is on a ‘long and expensive' road but stock may not ‘meaningfully underperform further,' analyst says

Intel Corp. is on a “long and expensive” path as it tries to recapture its former glory, but its st...

February 23, 2022, 11:40 am

Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain

OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. The key claim in the application covered the drug...

February 23, 2022, 2:30 am

Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain

OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. The key claim in the application covered the drug...

February 23, 2022, 2:30 am

Okyo pharma receives us patent for dry eye disease drug covering neuropathic pain

OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101. The key claim in the application covered the drug...

February 23, 2022, 2:30 am


Search within

Pages Search Results: